Anti-DPP-4 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the stalk region of human dipeptidyl peptidase 4 (DPP-4/CD26), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Rat, Pan, Monkey, Dog, Cat, Pig
UniProt
P27487
Size
100ug
Cat. #
RP3DPP4

In stock

SKU
RP-DPP4

Options

As low as: $130.00

Target Overview

Dipeptidyl peptidase 4 (DPP-4, EC 3.4.14.5) is a 766-residue type II transmembrane serine exopeptidase that functions both as a cell surface receptor and as a circulating protease (UniProt P27487). The enzyme removes N-terminal dipeptides from polypeptides with penultimate proline residues, cleaving substrates including incretin hormones (GLP-1, GIP), chemokines (CXCL10, CXCL12), and neuropeptides. As the T-cell activation antigen CD26, DPP-4 serves as a costimulatory receptor in T-cell receptor signaling, binding adenosine deaminase (ADA), caveolin-1 (CAV1), and other partners to promote lymphocyte activation and adhesion. The protein is expressed on activated T cells, endothelial cells, and epithelial surfaces, with soluble forms released into circulation. DPP-4 inhibitors (gliptins) are widely used in type 2 diabetes to prolong incretin activity, making this target central to metabolic research. The stalk region targeted by these antibodies lies between the transmembrane anchor and the catalytic domain, a region critical for membrane orientation and ectodomain shedding.

Background

DPP-4 plays dual roles in immune modulation and metabolic regulation. On T cells, its interaction with adenosine deaminase complexing protein 2 (ADCP-2) enhances lymphocyte-epithelial adhesion and provides costimulatory signals required for full T-cell activation. Binding to caveolin-1 and CARD11 triggers NF-κB activation in a TCR/CD3-dependent manner, amplifying proliferative responses. In the extracellular space, DPP-4 processes numerous bioactive peptides, including the cleavage and inactivation of glucagon-like peptide-1 (GLP-1), a key incretin hormone that stimulates insulin secretion. This proteolytic activity has made DPP-4 a validated drug target: DPP-4 inhibitors such as vildagliptin and sitagliptin prolong endogenous GLP-1 half-life and improve glycemic control in diabetes. Recent work extends DPP-4 biology beyond metabolism. Vildagliptin has been shown to modulate PI3K/AKT signaling and suppress NLRP3 inflammasome activation in rotenone-induced neurodegeneration models, suggesting neuroprotective potential independent of glycemic effects. DPP-4 also associates with fibroblast activation protein (FAP) in stromal remodeling and tumor microenvironments, where it contributes to extracellular matrix proteolysis and endothelial cell invasion. Coumarin-based DPP-4 inhibitors are under investigation as antidiabetic scaffolds with improved selectivity profiles. Three rabbit polyclonal antibodies targeting distinct epitopes in the stalk region are available from Triple Point Biologics, offering validated reagents for Western blot, immunohistochemistry, and immunofluorescence analysis of DPP-4 expression and localization across human and cross-reactive mammalian tissues.

References

  1. Patel D et al (2026) Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson's Disease. ACS Pharmacol Transl Sci. PubMed · DOI
  2. Verma S (2026) Coumarin derivatives as antidiabetic agents: a comprehensive review on mechanistic insights, structure-activity relationships, in silico studies, and challenges. Future Med Chem. PubMed · DOI
  3. Tu YK et al (2026) The association between sodium-glucose cotransporter 2 inhibitor and risk of pancreatic cancer among patients with type 2 diabetes mellitus: A real-world cohort study. Medicine (Baltimore). PubMed · DOI

Additional Specifications

Gene Symbol DPP4
UniProt ID P27487
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Rat, Pan, Monkey, Dog, Cat, Pig
Pack Size 100ug
Immunogen (Stalk region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-6.
Immunogen (spacer region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 55-240.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-766.
Alternate Names DPP-4, Dipeptidyl peptidase 4, Dipeptidyl peptidase IV, DPP IV, EC 3.4.14.5, CD26, T-cell activation antigen CD26, ADABP, Adenosine deaminase complexing protein 2, ADCP-2, TP103

Frequently Asked Questions

What molecular weight should I expect for DPP-4 on Western blot?

DPP-4 migrates as a band around 110 kDa on reducing SDS-PAGE, reflecting the full-length 766-residue type II transmembrane glycoprotein with extensive N-glycosylation. The predicted molecular weight of the polypeptide backbone is approximately 88 kDa, but post-translational glycosylation increases the apparent size. You may also detect a soluble circulating form around 110 kDa in serum or culture supernatants, produced by proteolytic shedding of the ectodomain. Start with the recommended 1:1000 dilution in TBST with 5% non-fat milk and optimize exposure time to capture both membrane-bound and soluble pools if present.

Is this DPP-4 antibody specific for the CD26 T-cell activation antigen?

Yes, DPP-4 and CD26 are the same protein. The antibody recognizes dipeptidyl peptidase 4, which is designated CD26 when functioning as a T-cell costimulatory receptor. The molecule is identical whether it is cleaving incretin hormones in the gut epithelium or binding adenosine deaminase on activated T lymphocytes. The antibody is validated in human samples where DPP-4 is expressed on activated T cells, endothelial cells, and epithelial surfaces. If you are studying T-cell activation, confirm expression levels in your stimulation model, as CD26 upregulation is antigen-dependent and may require 24-72 hours post-activation.

Does this antibody work in rat and mouse samples?

Human reactivity is validated; rat cross-reactivity is predicted based on epitope homology but not experimentally confirmed in-house. Mouse (Mus musculus) is not listed, which typically indicates lower sequence conservation in the immunogen region. Human and rat DPP-4 share approximately 85-90% identity, so cross-reactivity is plausible. We recommend empirical titration starting at 1:500 in rat lysates and running a positive control human lysate in parallel. If you require guaranteed mouse reactivity, request lot-specific validation data or consider a mouse-validated clone. Pan and monkey reactivities are also predicted and should be pilot-tested before committing to large experiments.

What starting dilution should I use for immunofluorescence with this DPP-4 antibody?

Although the recommended Western blot dilution is 1:1000, immunofluorescence typically requires more concentrated antibody. Start at 1:100 to 1:200 for cell monolayers or frozen sections, using PBS with 1-3% BSA and 0.1-0.3% Triton X-100 for permeabilized samples or omitting detergent for surface CD26 staining on intact cells. DPP-4 is a type II membrane protein with a large extracellular domain, so non-permeabilized staining is effective for visualizing surface expression on T cells or endothelium. Include a no-primary-antibody control and optimize incubation time between one hour at room temperature and overnight at four degrees Celsius.

What positive control lysate should I use to validate DPP-4 antibody performance?

Caco-2 human colorectal adenocarcinoma cells express high endogenous DPP-4 and serve as an excellent positive control. Alternatively, use lysates from activated human peripheral blood T cells, Jurkat T lymphocytes, or HUVEC endothelial cells, all of which express CD26. For negative controls, consider DPP-4 knockout cell lines if available, or pre-absorb the antibody with recombinant DPP-4 ectodomain to confirm specificity. Load 20-30 micrograms total protein per lane and expect a prominent 110 kDa band. If studying soluble DPP-4, human serum diluted 1:50 in sample buffer provides a physiological positive control for the circulating protease form.

Can I detect both membrane-bound and soluble DPP-4 with this antibody?

Yes, this polyclonal antibody recognizes epitopes present in both the membrane-anchored and soluble circulating forms of DPP-4. The soluble form is generated by proteolytic cleavage near the membrane anchor, releasing the catalytically active ectodomain into serum and other biological fluids. On Western blot, both forms migrate around 110 kDa and are indistinguishable by size alone. To differentiate them experimentally, fractionate samples into membrane and cytosolic fractions or compare whole-cell lysates with conditioned media or serum. For IHC, membrane staining appears as sharp surface or intercellular boundaries, whereas soluble DPP-4 may produce diffuse extracellular signal depending on fixation.

How should I store this antibody and what is the expected stability?

Store the antibody at minus twenty degrees Celsius in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. The 100 microgram pack size is suitable for dividing into 10-20 microliter aliquots upon receipt. For short-term use over one to two weeks, diluted working stocks can be held at four degrees Celsius with 0.02-0.05% sodium azide as preservative, though neat stock should remain frozen. Rabbit polyclonal antibodies from Triple Point Biologics typically retain activity for two to three years under these conditions. Avoid prolonged exposure to room temperature and ensure the vial is tightly sealed to prevent lyophilization or concentration changes. Centrifuge briefly before each use to pellet any aggregates.

Will this DPP-4 antibody detect the enzyme in its active conformation?

This polyclonal antibody is raised against a recombinant fragment and recognizes linear or denatured epitopes, making it well-suited for Western blot and IHC where protein structure is partially or fully disrupted. It is not conformation-dependent and will detect DPP-4 regardless of enzymatic activity status or inhibitor binding. If you need to correlate antibody signal with catalytic activity, pair immunoblotting with an enzymatic assay using a fluorogenic dipeptide substrate such as Gly-Pro-AMC. The antibody does not distinguish between active enzyme and catalytically inactive mutants or inhibitor-bound complexes. For native immunoprecipitation or flow cytometry, empirical testing is required since epitope accessibility may differ in the folded extracellular domain.

Western blot validation for RP-DPP4 — 3 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

DPP-4: Stalk region — WB validation
WB · Panel 1 DPP-4: Stalk region
DPP-4: spacer region — WB validation
WB · Panel 2 DPP-4: spacer region
DPP-4: Catalytic domain — WB validation
WB · Panel 3 DPP-4: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • DPP-4
  • Dipeptidyl peptidase 4
  • Dipeptidyl peptidase IV
  • DPP IV
  • EC 3.4.14.5
  • CD26
  • T-cell activation antigen CD26
  • ADABP
  • Adenosine deaminase complexing protein 2
  • ADCP-2
  • TP103
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →